Calendar Halozyme Therapeutics, Inc.

Equities

HALO

US40637H1095

Real-time Estimate Cboe BZX 12:18:29 30/04/2024 am IST 5-day change 1st Jan Change
38.9 USD +0.86% Intraday chart for Halozyme Therapeutics, Inc. +0.70% +5.47%

Chart calendar Halozyme Therapeutics, Inc.

8f266249b96c030b23d9ece.FjdE9P-nGJtF7iMEKjclx5xWcbzCZjEsXfBZDrbyI_8.ImQGnsfeQfd2w2xVTQNht6VuFO-1CGIaGsgBYMetULlGfyiDkNQs8wSGTA~a54b52057d95ab403eba3812a7d0e6b0

Upcoming events on Halozyme Therapeutics, Inc.

08/05/2024 01:31 am Q1 2024 Earnings Release
08/05/2024 02:00 am Q1 2024 Earnings Call
06/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
25/02/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Halozyme Therapeutics, Inc.

26/04/2024 12:30 am Annual General Meeting
13/03/2024 08:15 pm Barclays Global Healthcare Conference
13/03/2024 12:30 am Leerink Partners Global Biopharma Conference
06/03/2024 01:20 am TD Cowen Health Care Conference
21/02/2024 03:00 am Q4 2023 Earnings Call
21/02/2024 02:31 am Q4 2023 Earnings Release
17/01/2024 07:00 pm Business Update Call
29/11/2023 11:00 pm Evercore ISI HealthCONx Conference
29/11/2023 06:30 pm Piper Sandler Healthcare Conference
07/11/2023 03:00 am Q3 2023 Earnings Call
07/11/2023 02:31 am Q3 2023 Earnings Release
17/10/2023 08:05 pm Partnership Opportunities in Drug Delivery Conference
13/09/2023 10:55 pm Baird Global Healthcare Conference
12/09/2023 08:20 pm Morgan Stanley Global Healthcare Conference
11/09/2023 07:00 pm H.C. Wainwright Global Investment Conference
07/09/2023 05:30 pm Wells Fargo Healthcare Conference
09/08/2023 02:00 am Q2 2023 Earnings Call
09/08/2023 01:31 am Q2 2023 Earnings Release
13/06/2023 08:30 pm Goldman Sachs Global Healthcare Conference
23/05/2023 Benchmark Healthcare House Call Virtual Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
196
197
-0.69%
268
265
0.89%
443
442
0.4%
660
672
-1.74%
829
830
-0.13%

954

EBITDA
Million USD
Released
Forecast
Spread
-63,5
-56,4
-12.67%
148
144
2.66%
279
278
0.26%
315
339
-7.01%
426
414
3.04%

544

EBIT
Million USD
Released
Forecast
Spread
-67,6
-60,2
-12.29%
144
148
-2.83%
276
276
-0.04%
268
286
-6.39%
338
344
-1.85%

475

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-72,3
-64,1
-12.79%
129
135
-4.33%
249
250
-0.74%
249
229
8.89%
348
349
-0.08%

472

Net income
Million USD
Released
Forecast
Spread
-72,2
-63,8
-13.27%
129
132
-2.57%
403
392
2.8%
202
183
10.35%
282
279
0.92%

370

EPS
USD
Released
Forecast
Spread
-0,50
-0,44
-14.43%
0,91
0,93
-2.4%
2,74
2,68
2.07%
1,44
1,32
9.33%
2,10
2,07
1.29%

3,02

Announcement Date24/02/2023/02/2122/02/2221/02/2320/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
102
99,7
2.32%
117
129
-8.74%
152
156
-2.33%
209
191
9.31%
181
192
-5.5%
162
176
-7.62%
221
200
10.55%
216
216
-0.04%
230
231
-0.48%

201


208


253


292


243

EBITDA
Million USD
Released
Forecast
Spread
57,3
60,0
-4.49%
81,2
90,0
-9.79%
40,8


85,3
105
-18.76%
79,5
98,0
-18.93%
74,5
83,0
-10.2%
115
108
6.38%
115
119
-3.18%
122
126
-3.48%

116


112


144


190




EBIT
Million USD
Released
Forecast
Spread
56,5
58,3
-3.11%
75,7
85,7
-11.65%
34,1
88,9
-61.68%
83,3
79,1
5.29%
74,5
65,7
13.47%
53,8
68,5
-21.44%
94,5
87,4
8.04%
88,3
94,0
-6.07%
101
109
-7.05%

90,8


94,1


135


155


145

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
54,8
55,9
-1.96%
74,4
80,5
-7.58%
30,0
88,2
-65.97%
73,7
64,5
14.36%
70,8
48,5
46.02%
52,2
57,6
-9.38%
93,2
83,7
11.26%
102
88,6
14.89%
101
104
-2.82%

93,3


92,8


133


155


141

Net income
Million USD
Released
Forecast
Spread
66,8
55,0
21.34%
60,1
63,6
-5.52%
22,7
67,9
-66.59%
61,6
48,2
27.92%
57,7
36,0
60.34%
39,6
43,3
-8.56%
74,8
65,6
13.95%
81,8
70,5
16.03%
85,4
84,8
0.68%

72,0


71,7


106


126


113

EPS
USD
Released
Forecast
Spread
0,46
0,38
20.26%
0,43
0,46
-6.52%
0,16
0,47
-65.59%
0,44
0,36
21.66%
0,42
0,28
49.24%
0,29
0,32
-9.85%
0,57
0,47
20.91%
0,61
0,52
18.28%
0,65
0,64
1.04%

0,59


0,61


0,86


0,99


0,94

Announcement Date22/02/2210/05/2209/08/2208/11/2221/02/2309/05/2308/08/2306/11/2320/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HALO Stock
  4. Calendar Halozyme Therapeutics, Inc.